Skip to main content
Cell Cycle logoLink to Cell Cycle
. 2022 Mar 17;21(8):878. doi: 10.1080/15384101.2022.2046820

Statement of Retraction: Upregulation of microRNA-204 improves insulin resistance of polycystic ovarian syndrome via inhibition of HMGB1 and the inactivation of the TLR4/NF-κB pathway

PMCID: PMC8973351  PMID: 35297296

We, the Editors and Publisher of the journal Cell Cycle, have retracted the following article:

Bin Jiang, Min Xue, Dabao Xu, Yujia Song, and Shujuan Zhu. Upregulation of microRNA-204 improves insulin resistance of polycystic ovarian syndrome via inhibition of HMGB1 and the inactivation of the TLR4/NF-κB pathway. Cell Cycle. 2020;19(6):697-710. doi: 10.1080/15384101.2020.1724601.

Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors have been unable to address the concerns raised and have not been able to provide their original data. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.


Articles from Cell Cycle are provided here courtesy of Taylor & Francis

RESOURCES